Clinical Trials in Chicago

Showing 4241-4260 of 20,493 trials

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

NCT06427824

This study focuses on providing an educational program for people/participants with bladder cancer who plan to have a cystectomy (surgery) as part of their standard care. Participants in this study will watch videos designed to teach them strategies to help lower their risk of experiencing negative side effects (such as mobility problems, issues with taking medication, and poor quality of life) before and after they have surgery. They will also be asked to fill out questionnaires.

Bladder Cancer

University of Chicago85 participantsStarted Aug 2024

Chicago, Illinois, United States

Active Not RecruitingPhase 32.2 miles

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

NCT05367960

This is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-301 (in adult males) and Study BPN14770-CNS-204 (in adolescent males).

Fragile X Syndrome

Tetra Discovery Partners314 participantsStarted Nov 2022

Irvine, California, United States • Orange, California, United States • Sacramento, California, United States +14 more locations

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Find Trials by Condition in Chicago

Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

Long-Term Outcomes of Early Communication Intervention for Deaf/Hard of Hearing Toddlers

A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

MB-105 in Patients With CD5 Positive T-cell Lymphoma

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Hyperbaric Oxygen Brain Injury Treatment Trial

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain